Crystal structure determination of compound 4‡
left stirring for a further 4 h at 90–95 ◦C, cooled to room temper-
ature and the solvent was removed under reduced pressure to give
the target compound as two diastereoisomers in a ratio of (85 :
15) (0.246 g, 89% conversion). A sample was recrystallised from
CH2Cl2–petroleum ether 40–60 ◦C (diffusion recrystallisation) to
afford a white solid of the major diastereois◦omer 12. Mp 215–
217 ◦C (from CH2Cl2–petroleum ether 40–60 C); [a]2D5 +25.0 (c 1
Crystal data. C25H23NO, M = 353.44, monoclinic, a =
3
˚
˚
18.188(3), b = 7.0490(10), c = 17.257(2) A, U = 1891.7(5) A ,
T = 150(2) K, space group C2, Z = 4, l(Mo–Ka) = 0.075 mm−1,
10741 reflections measured, 2328 unique (Rint = 0.0406) which
were used in all calculations. The final wR(F2) was 0.0943 (all
data).
in CHCl3); mmax/cm−1 1692 (C O); dH(250 MHz; CDCl3; Me4Si)
=
2.41 (3H, s, CH3), 2.54 (3H, s, CH3), 2.93 (1H, dd, J 13.5 and 8.2,
CHHPh), 3.05 (1H, dd, J 8.4 and 3.3, CHHPh), 3.15–3.33 (2H,
m, PhCHC(O)CH and CHN), 3.72 (1H, d, J 8.4, C(O)CH), 3.92
(1H, app t, J 7.8, CHHO), 4.15 (1H, app t, J 7.8, CHHO), 4.69
(1H, d, J 3.3, PhCHCH), 5.84 (1H, s, NCHO), 7.03–7.39 (11H,
m, ArCH), 7.53–7.60 (1H, m, ArCH), 8.61 (1H, d, J 7.9, ArCH);
dC(62.5 MHz; CDCl3; Me4Si) 24.1 (CH3), 37.4 (CH2), 37.6 (CH3),
46.8 (CH), 48.0 (CH), 49.2 (CH), 49.8 (C), 66.4 (CH), 69.3 (CH2),
94.0 (CH), 123.4 (CH), 124.1 (CH), 125.1 (CH), 125.9 (CH),
126.1 (CH), 126.3 (CH), 126.6 (CH), 126.8 (CH), 128.1 (CH),
128.5 (CH), 128.7 (C), 129.4 (CH), 137.8 (C), 138.4 (C), 138.9
(C), 141.9 (C), 175.8 (C), 176.7 (C); m/z (ES) 465.2168 (MH+.
C30H29N2O3 requires 465.2178).
(2S,4S)-2-(9-Anthracenyl)-3,4-dibenzyl oxazolidine 5
A solution of N-benzylphenylalaninol 1116 (0.76 g, 3.15 mmol) in
dry CH2Cl2 (10 cm3) was added dropwise at room temperature to a
stirred mixture of anthracene-9-carboxaldehyde (0.5 g, 2.43 mmol)
and Mg(OTf)2 (0.08 g, 0.248 mmol) in dry CH2Cl2 (10 cm3). The
resulting mixture was stirred for 48 h at room temperature, filtered
through Celite and the solvent was removed to give a yellow solid
as a mixture of diastereoisomers (85 : 15) which was recrystallised
from CH2Cl2–petroleum ether 40–60 ◦C to provide a single isomer
of the desired oxazolidine 5 (0.91 g, 85%). Mp 101–103 ◦C (from
CH2Cl2–petroleum ether 40–60 ◦C); (found: C, 86.8; H, 6.6; N,
3.2. C31H27NO requires C, 86.7; H, 6.3; N, 3.3%); [a]2D5 −22.0 (c 1
1
in CHCl3); mmax/cm−1 1491 and 1452 (C C); dH(250 MHz; CDCl3;
Selected H NMR signals for the minor diastereoisomer 13.
dH(250 MHz; CDCl3; Me4Si) 3.66 (1H, d, J 7.9, C(O)CH), 4.66
(1H, d, J 3.4, PhCHCH), 5.82 (s, 1H).
=
Me4Si) 2.79 (1H, dd, J 13.4 and 9.5, CHHPh), 2.89 (1H, dd, J
13.4 and 4.3, CHHPh), 3.36–3.50 (1H, m, CHN), 3.62 (1H, d,
J 13.7, CHHPh), 3.75 (1H, d, J 13.7, CHHPh), 4.15 (1H, app
t, J 7.7, CHHO), 4.22 (1H, app t, J 7.7, CHHO), 6.48 (1H, s,
NCHO), 6.86–6.99 (4H, m, ArCH), 7.12–7.76 (10H, m, ArCH),
7.97 (2H, d, J 7.9, ArCH), 8.42 (1H, s, ArCH), 8.91 (2H, d, J 8.2,
ArCH); dC(62.5 MHz; CDCl3; Me4Si) 40.2 (CH2), 55.1 (CH2),
65.6 (CH), 71.5 (CH2), 93.5 (CH), 124.7 (CH), 124.8 (CH), 125.1
(CH), 125.3 (CH), 125.5 (CH), 125.8 (CH), 126.4 (CH), 126.7
(CH), 127.6 (CH), 128.0 (CH), 128.6 (CH), 128.7 (CH), 129.0
(CH), 129.1 (CH), 129.3 (CH), 129.9 (CH), 131.5 (C), 131.6 (C),
138.2 (C), 138.7 (C); m/z (EI) 429.2091 (M+. C31H27NO requires
429.2093), 429 (9%), 338 (93), 269 (6), 252 (7), 206 (8), 178 (28),
157 (8), 91 (100).
Crystal structure determination of compound 12‡
Crystal data. C31H30Cl2N2O3, M = 549.47, monoclinic, a =
3
˚
˚
7.6834(10), b = 10.5554(14), c = 16.299(2) A, U = 1319.4(3) A ,
T = 150(2) K, space group P21, Z = 2, l(Mo–Ka) = 0.283 mm−1,
11779 reflections measured, 3123 unique (Rint = 0.0224) which
were used in all calculations. The final wR(F2) was 0.0766 (all
data).
(3aS,9aS)-3a,4,9,9a-Tetrahydro-4-[(2R,4S)-3,5-dibenzyl-
2-oxazolidinyl]-2-methyl-4,9[1ꢀ,2ꢀ]-benzeno-1H-benz[f ]isoindole-
1,3(2H)-dione 17
Selected 1H NMR signals for the minor diastereoisomer.
dH(250 MHz; CDCl3; Me4Si) 3.14 (1H, dd, J 12.2 and 4, CHHPh),
3.92 (1H, dd, J 8.5 and 3.6, CHHO), 4.40 (1H, dd, J 8.5 and 6.4,
CHHO), 6.87 (1H, s, NCHO), 8.50 (1H, s, ArCH).
N-Methyl maleimide (0.129 g, 1.160 mmol) was added in one
portion as a solid at 90–95 ◦C to a stirred solution of oxazolidine
5 (0.5 g, 1.16 mmol) in toluene (10 cm3). The resulting mixture
was left stirring for 4 h at 90–95 ◦C, cooled to room temperature
and the solvent was removed under reduced pressure to give a
single diastereoisomer of the target cycloadduct (0.47 g, 75%).
A sample was recrystallised from CH2Cl2–petroleum ether 40–
60 ◦C (diffusion recrystallisation) to afford a white solid of the
title compound 17. Mp 204–207 ◦C from CH2Cl2–petroleum ether
40–60 ◦C); (found: C, 79.7; H, 5.9; N, 5.1. C36H32N2O3 requires C,
80.0; H, 6.0; N, 5.2%); [a]2D5 +66.1 (c 1 in CHCl3); mmax/cm−1 1688
Crystal structure determination of compound 5‡
Crystal data. C31H27NO, M = 429.54, triclinic, a = 7.284(3),
3
˚
˚
b = 9.462(3), c = 18.426(6) A, U = 1144.2(7) A , T = 293(2) K,
space group P1, Z = 2, l(Mo–Ka) = 0.074 mm−1, 12849 reflections
measured, 5114 unique (Rint = 0.0593) which were used in all
calculations. The final wR(F2) was 0.1422 (all data).
(3aR,9aR)-3a,4,9,9a-Tetrahydro-4-[(2S,4S)-5-benzyl-3-methyl-2-
oxazolidinyl]-2-methyl-4,9[1ꢀ,2ꢀ]-benzeno-1H-benz[f ]isoindole-
1,3(2H)-dione 12
=
=
(C O), 1454, 1428 and 1376 (C C); dH(250 MHz; CDCl3; Me4Si)
2.50 (3H, s, CH3), 2.81 (1H, dd, J 13.4 and 10.0, CHHPh), 3.01
(1H, dd, J 13.4 and 5.1, CHHPh), 3.10 (1H, dd, J 8.3 and 3.1,
PhCHC(O)CH), 3.60 (1H, d, J 8.3, C(O)CH), 3.63–3.71 (3H, m,
CH2Ph and CHN), 3.83 (1H, dd, J 8.3 and 4.2, CHHO), 4.15
(1H, dd, J 8.3 and 6.4, CHHO), 4.77 (1H, d, J 3.1, PhCHCH),
6.55 (1H, s, NCHO), 7.00–7.04 (2H, m, ArCH), 7.06–7.46 (14H,
m, ArCH), 8.10 (1H, dd, J 7.0 and 1.8, ArCH), 8.17 (1H, dd, J 6.7
and 2.2, ArCH); dC(62.5 MHz; CDCl3; Me4Si) 24.3 (CH3), 38.4
(CH2), 46.6 (CH), 48.3 (CH), 49.8 (CH), 50.3 (CH2), 56.6 (CH2),
N-Methyl maleimide (0.083 g, 0.75 mmol) was added in one
portion as a solid at 90–95 ◦C to a stirred solution of oxazolidine 4
(0.177 g, 0.5 mmol) in toluene (3 cm3). The resulting mixture was
‡ CCDC reference numbers 614833 (4), 614834 (5), 614835 (12) and 614836
(17). For crystallographic data in CIF or other electronic format see DOI:
10.1039/b610055d
4212 | Org. Biomol. Chem., 2006, 4, 4206–4213
This journal is
The Royal Society of Chemistry 2006
©